Episode Details

Back to Episodes

Experimental cancer vaccine extending live expectancy

Published 2 months, 3 weeks ago
Description
A deeply compelling innovation has got cancer specialists buzzing. An experimental m-R-N-A cancer vaccine which has allowed people with high-risk melanoma to live longer, cancer-free, according to drug companies Moderna and Merck. Medical Oncologist and Melanoma NZ Spokesperson Gareth Rivalland has been leading this from the New Zealand end joined us to discuss.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us